Liz Zambricki, M.D.
Planned Year of Completion: 2016
 |
Liz Zambricki, M.D.
-
Hometown: Bloomfield Hills, Michigan
- Medical School: Stanford University
- Graduate: Stanford University (MBA)
- Undergraduate: University of Michigan
Publications
- Zambricki EA, Ootani A, Mancuso M, Zeiser R, Kuo CJ, Negrin RS. Use of R-spondin1, an intestinotrophic mitogen, in
the treatment of murine graft-versus-host-disease. unknown. Pub Status: Submitted.
- Zambricki E, Shigeoka A, Kishimoto H, Sprent J, Burakoff S, Carpenter C, Milford E, McKay D. Signaling T-cell
survival and death by IL-2 and IL-15. American Journal of Transplantation.2005 Nov; 5(11): 2623-2631. Cited in
PubMed; PMID: 16212621.
- Zambricki E, Zal T, Yachi P, Shigeoka A, Sprent J, Gascoigne N, McKay D. In vivo anergized T cells form altered
immunological synapses in vitro. American Journal of Transplantation.2006 Nov; 6(11): 2572-2579. Cited in PubMed;
PMID: 16952297.
- Zambricki EA, D'Alecy LG. Rat sex differences in anesthesia. Comparative Medicine.2004 Feb; 54(1): 49-53. Cited in
PubMed; PMID: 15027618.
- Zeiser R, Levenson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS. Differential impact
of mTOR inhibition on CD4+CD25+FoxP3+ regulatory T cells a compared to conventional CD4+ T cells. Blood.2008
Jan; 111(1): 453-462. Cited in PubMed; PMID: 17967941.
- Zeiser R, Nguyen VH, Hou JZ, Beilhack A, Zambricki EA, Buess M, Contag CH, Negrin RS. Early CD30 signaling is
critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host-disease.
Blood.2007 Mar; 109(5): 2225-2233. Cited in PubMed; PMID: 17068147.
- Zeiser R, Zambricki EA, Leveson-Gower D, Kambham N, Beilhack A, Negrin RS. Host-derived interleukin-18
differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host-disease. Biology of
Blood and Marrow Transplantation.2007 Dec; 13(12): 1427-1438. Cited in PubMed; PMID: 18022572.
|
|
|
